Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells

doi:10.1084/jem.175.1.139

This Article

	Full Text (PDF, 799K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Singh, S.
	Articles by Schreiber, H.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Singh, S.
	Articles by Schreiber, H.


Social Bookmarking

	What's this?

ARTICLES

Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells

S Singh, SR Ross, M Acena, DA Rowley and H Schreiber
Department of Pathology, University of Chicago, Illinois 60637.

Inoculated immunogenic cancer cells after initial growth are potentially rejected by specific host immunity; however, the outcome of the interaction between host and inoculated cancer cells is a function of multiple factors including the route of inoculation, the number of cells, the density of antigens on the injected cancer cells, and the state of the immune system of the host. In the present study, we have examined a different kind of variable: the stroma that inoculated tumor cells initially reside in. The impetus to examine this factor arises from observations that cancer cells from several lines inoculated as fragments of solid tumors often grow progressively, whereas the same number or more than 10-fold larger numbers of identical type cells injected as a suspension are rejected, even though fragments or suspended cells are both tumorigenic at the same doses in nude mice. In the present studies, we found that: (a) indeed, cancer cells inoculated as fragments were more tumorigenic than cancer cells in suspension; (b) the tumorigenicity of suspended cancer cells was increased by injection of the cells into polyurethane sponge implants; (c) cancer cells were more tumorigenic embedded in syngeneic stroma than in transgenic antigenic stroma expressing the K216 major histocompatibility complex class I antigen; and (d) antigenic, bone marrow-derived, stromal components (presumably passenger leukocytes) were sufficient to cause rejection of immunogenic but antigenically unrelated cancer.(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Thomas, D. L., Kim, M., Bowerman, N. A., Narayanan, S., Kranz, D. M., Schreiber, H., Roy, E. J. (2009). Recurrence of Intracranial Tumors following Adoptive T Cell Therapy Can Be Prevented by Direct and Indirect Killing Aided by High Levels of Tumor Antigen Cross-Presented on Stromal Cells. J. Immunol. 183: 1828-1837 [Abstract] [Full Text]
Zhang, B. (2008). Targeting the Stroma by T Cells to Limit Tumor Growth. Cancer Res. 68: 9570-9573 [Abstract] [Full Text]
Tatum, A. M., Mylin, L. M., Bender, S. J., Fischer, M. A., Vigliotti, B. A., Tevethia, M. J., Tevethia, S. S., Schell, T. D. (2008). CD8+ T Cells Targeting a Single Immunodominant Epitope are Sufficient for Elimination of Established SV40 T Antigen-Induced Brain Tumors. J. Immunol. 181: 4406-4417 [Abstract] [Full Text]
Hambach, L., Vermeij, M., Buser, A., Aghai, Z., van der Kwast, T., Goulmy, E. (2008). Targeting a single mismatched minor histocompatibility antigen with tumor-restricted expression eradicates human solid tumors. Blood 112: 1844-1852 [Abstract] [Full Text]
Chow, K.-P. N, Wu, C C, Chang, H Y, Chang, C, Chang, Y S (2008). A simplified tumour model established via Epstein-Barr virus-encoded, nasopharyngeal carcinoma-derived oncogene latent membrane protein 1 in immunocompetent mice. Lab Anim 42: 193-203 [Abstract] [Full Text]
Zhang, B., Zhang, Y., Bowerman, N. A., Schietinger, A., Fu, Y.-X., Kranz, D. M., Rowley, D. A., Schreiber, H. (2008). Equilibrium between Host and Cancer Caused by Effector T Cells Killing Tumor Stroma. Cancer Res. 68: 1563-1571 [Abstract] [Full Text]
Otahal, P., Knowles, B. B., Tevethia, S. S., Schell, T. D. (2007). Anti-CD40 Conditioning Enhances the TCD8 Response to a Highly Tolerogenic Epitope and Subsequent Immunotherapy of Simian Virus 40 T Antigen-Induced Pancreatic Tumors. J. Immunol. 179: 6686-6695 [Abstract] [Full Text]
Lin, K.-Y., Lu, D., Hung, C.-F., Peng, S., Huang, L., Jie, C., Murillo, F., Rowley, J., Tsai, Y.-C., He, L., Kim, D.-J., Jaffee, E., Pardoll, D., Wu, T.-C. (2007). Ectopic Expression of Vascular Cell Adhesion Molecule-1 as a New Mechanism for Tumor Immune Evasion. Cancer Res. 67: 1832-1841 [Abstract] [Full Text]
Zhang, B., Bowerman, N. A., Salama, J. K., Schmidt, H., Spiotto, M. T., Schietinger, A., Yu, P., Fu, Y.-X., Weichselbaum, R. R., Rowley, D. A., Kranz, D. M., Schreiber, H. (2007). Induced sensitization of tumor stroma leads to eradication of established cancer by T cells. JEM 204: 49-55 [Abstract] [Full Text]
Dobrzanski, M. J., Reome, J. B., Hylind, J. C., Rewers-Felkins, K. A. (2006). CD8-Mediated Type 1 Antitumor Responses Selectively Modulate Endogenous Differentiated and Nondifferentiated T Cell Localization, Activation, and Function in Progressive Breast Cancer. J. Immunol. 177: 8191-8201 [Abstract] [Full Text]
Hargadon, K. M., Brinkman, C. C., Sheasley-O'Neill, S. L., Nichols, L. A., Bullock, T. N. J., Engelhard, V. H. (2006). Incomplete Differentiation of Antigen-Specific CD8 T Cells in Tumor-Draining Lymph Nodes. J. Immunol. 177: 6081-6090 [Abstract] [Full Text]
Nelson, D., Ganss, R. (2006). Tumor growth or regression: powered by inflammation. J. Leukoc. Biol. 80: 685-690 [Abstract] [Full Text]
Hicks, A. M., Riedlinger, G., Willingham, M. C., Alexander-Miller, M. A., Von Kap-Herr, C., Pettenati, M. J., Sanders, A. M., Weir, H. M., Du, W., Kim, J., Simpson, A. J. G., Old, L. J., Cui, Z. (2006). Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proc. Natl. Acad. Sci. USA 103: 7753-7758 [Abstract] [Full Text]
Berhanu, A., Huang, J., Alber, S. M., Watkins, S. C., Storkus, W. J. (2006). Combinational FLt3 Ligand and Granulocyte Macrophage Colony-Stimulating Factor Treatment Promotes Enhanced Tumor Infiltration by Dendritic Cells and Antitumor CD8+ T-Cell Cross-priming but Is Ineffective as a Therapy.. Cancer Res. 66: 4895-4903 [Abstract] [Full Text]
Kryczek, I., Zou, L., Rodriguez, P., Zhu, G., Wei, S., Mottram, P., Brumlik, M., Cheng, P., Curiel, T., Myers, L., Lackner, A., Alvarez, X., Ochoa, A., Chen, L., Zou, W. (2006). B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. JEM 203: 871-881 [Abstract] [Full Text]
Yu, P., Lee, Y., Liu, W., Krausz, T., Chong, A., Schreiber, H., Fu, Y.-X. (2005). Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. JEM 201: 779-791 [Abstract] [Full Text]
Guiducci, C., Di Carlo, E., Parenza, M., Hitt, M., Giovarelli, M., Musiani, P., Colombo, M. P. (2004). Intralesional Injection of Adenovirus Encoding CC Chemokine Ligand 16 Inhibits Mammary Tumor Growth and Prevents Metastatic-Induced Death after Surgical Removal of the Treated Primary Tumor. J. Immunol. 172: 4026-4036 [Abstract] [Full Text]
Blohm, U., Roth, E., Brommer, K., Dumrese, T., Rosenthal, F. M., Pircher, H. (2002). Lack of Effector Cell Function and Altered Tetramer Binding of Tumor-Infiltrating Lymphocytes. J. Immunol. 169: 5522-5530 [Abstract] [Full Text]
Wang, L.-X., Chen, B.-G., Plautz, G. E. (2002). Adoptive Immunotherapy of Advanced Tumors with CD62 L-Selectinlow Tumor-Sensitized T Lymphocytes Following Ex Vivo Hyperexpansion. J. Immunol. 169: 3314-3320 [Abstract] [Full Text]
Igney, F. H., Krammer, P. H. (2002). Immune escape of tumors: apoptosis resistance and tumor counterattack. J. Leukoc. Biol. 71: 907-920 [Abstract] [Full Text]
Ganss, R., Ryschich, E., Klar, E., Arnold, B., Hammerling, G. J. (2002). Combination of T-Cell Therapy and Trigger of Inflammation Induces Remodeling of the Vasculature and Tumor Eradication. Cancer Res. 62: 1462-1470 [Abstract] [Full Text]
Ibe, S., Qin, Z., Schuler, T., Preiss, S., Blankenstein, T. (2001). Tumor Rejection by Disturbing Tumor Stroma Cell Interactions. JEM 194: 1549-1560 [Abstract] [Full Text]
Dobrzanski, M. J., Reome, J. B., Dutton, R. W. (2001). Role of Effector Cell-Derived IL-4, IL-5, and Perforin in Early and Late Stages of Type 2 CD8 Effector Cell-Mediated Tumor Rejection. J. Immunol. 167: 424-434 [Abstract] [Full Text]
Kacha, A. K., Fallarino, F., Markiewicz, M. A., Gajewski, T. F. (2000). Spontaneous Rejection of Poorly Immunogenic P1.HTR Tumors by Stat6-Deficient Mice. J. Immunol. 165: 6024-6028 [Abstract] [Full Text]
Rovero, S., Amici, A., Carlo, E. D., Bei, R., Nanni, P., Quaglino, E., Porcedda, P., Boggio, K., Smorlesi, A., Lollini, P.-L., Landuzzi, L., Colombo, M. P., Giovarelli, M., Musiani, P., Forni, G. (2000). DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice. J. Immunol. 165: 5133-5142 [Abstract] [Full Text]
Forni, G., Lollini, P. L., Musiani, P., Colombo, M. P. (2000). Immunoprevention of Cancer: Is the Time Ripe?. Cancer Res. 60: 2571-2575 [Abstract] [Full Text]
Willimsky, G., Blankenstein, T. (2000). Interleukin-7/B7.1-encoding Adenoviruses Induce Rejection of Transplanted but not Nontransplanted Tumors. Cancer Res. 60: 685-692 [Abstract] [Full Text]
Zheng, P., Sarma, S., Guo, Y., Liu, Y. (1999). Two Mechanisms for Tumor Evasion of Preexisting Cytotoxic T-Cell Responses: Lessons from Recurrent Tumors. Cancer Res. 59: 3461-3467 [Abstract] [Full Text]
Marzo, A. L., Lake, R. A., Robinson, B. W. S., Scott, B. (1999). T-Cell Receptor Transgenic Analysis of Tumor-specific CD8 and CD4 Responses in the Eradication of Solid Tumors. Cancer Res. 59: 1071-1079 [Abstract] [Full Text]
Horiuchi, A., Nikaido, T., Ya-Li, Z., Ito, K., Orii, A., Fujii, S. (1999). Heparin inhibits proliferation of myometrial and leiomyomal smooth muscle cells through the induction of {alpha}-smooth muscle actin, calponin h1 and p27. Mol Hum Reprod 5: 139-145 [Abstract] [Full Text]
Wick, M., Dubey, P., Koeppen, H., Siegel, C. T., Fields, P. E., Chen, L., Bluestone, J. A., Schreiber, H. (1997). Antigenic Cancer Cells Grow Progressively in Immune Hosts without Evidence for T Cell Exhaustion or Systemic Anergy. JEM 186: 229-238 [Abstract] [Full Text]